Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophilic esophagitis.

Richard J Noel1, Marc E Rothenberg

  • 1Division of Pediatric Gastroenterology and Nutrition, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Current Opinion in Pediatrics
|November 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eosinophilic Gastrointestinal Disorders Prevention: Insights From Early Life Influences and Atopic Conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

The lancet. Gastroenterology & hepatology·2026
Same author

Tissue remodeling in eosinophilic esophagitis.

The Journal of allergy and clinical immunology·2026
Same author

Antigen-specific messenger RNA lipid nanoparticle therapy with mTOR inhibition promotes regulatory T cells and limits allergy.

The Journal of allergy and clinical immunology·2026
Same author

Collaboration as a Catalyst for Advancing Rare Disease Research: The Experience of the Rare Diseases Clinical Research Network.

Clinical and translational science·2026
Same author

Emerging insights into the presentation, pathophysiology, and management of eosinophilic esophagitis.

The Journal of allergy and clinical immunology·2026
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Eosinophilic esophagitis (EoE) is increasingly diagnosed, with research now focusing on immunologic factors and therapies. While initial treatments show efficacy, long-term outcome data is needed for standardized patient care guidelines.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pathology

Background:

  • Eosinophilic esophagitis (EoE) is increasingly diagnosed across pediatric and adult populations.
  • Initial research focused on clinical, endoscopic, and histologic features.
  • Recent research has shifted to immunologic, demographic aspects, and therapeutic development.

Purpose of the Study:

  • To review the evolving understanding of eosinophilic esophagitis.
  • To highlight recent advancements in its diagnosis and treatment.
  • To identify gaps in long-term outcome data.

Main Methods:

  • Review of population-based demographic studies.
  • Analysis of basic research on relevant cytokines (e.g., IL-5, IL-13).
  • Evaluation of clinical trial data on dietary and medical treatments.

Related Experiment Videos

Main Results:

  • EoE exhibits unique epidemiologic parameters and increasing frequency.
  • Key cytokines like IL-5 and IL-13 are implicated in EoE development.
  • Dietary and medical treatments demonstrate efficacy, though long-term effects of asymptomatic inflammation are debated.

Conclusions:

  • Current understanding allows for appropriate diagnosis and initial treatment of EoE.
  • A lack of long-term outcome data hinders the development of uniform clinical care recommendations.